Baudax Bio, Inc.

BXRXQ · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$58,795-$19,769-$76,100-$32,557
Dep. & Amort.$2,162$2,816$2,554$480
Deferred Tax$0$0$0$0
Stock-Based Comp.$1,401$4,789$9,341$5,463
Change in WC$62-$3,080$633-$8,876
Other Non-Cash$27,377-$34,026$19,514-$14,554
Operating Cash Flow-$27,793-$49,270-$44,058-$50,044
Investing Activities
PP&E Inv.-$20-$203-$639-$1,319
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$19,641$0$0
Inv. Sales/Matur.$0$19,650$0$0
Other Inv. Act.$0$0$0-$165
Investing Cash Flow-$20-$194-$639-$1,484
Financing Activities
Debt Repay.-$2,244$0$10,041$0
Stock Issued$20,399$30,824$45,010$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$974$4,189$2,248$69,268
Financing Cash Flow$17,181$35,013$57,299$69,268
Forex Effect$0$0$0$0
Net Chg. in Cash-$10,632-$14,451$12,602$17,740
Supplemental Information
Beg. Cash$15,891$30,342$17,740$0
End Cash$5,259$15,891$30,342$17,740
Free Cash Flow-$27,813-$49,473-$44,697-$51,528